R&D Systems™ Recombinant Human VSIG8 Fc Chimera Biotinylated Protein, CF

Catalog No.	Quantity
BT9200050	50 μg

Catalog No. BT9200050 Supplier R&D Systems™ Supplier No. BT9200050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 1-5 μg/mL.

Specifications

• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in Sodium Acetate and Mannitol with Trehalose.
• Gene ID (Entrez): 391123
• Molecular Weight (g/mol): M.W. (Observed): 56-67 kDa, reducing conditions; M.W. (theoretical): 54 kDa (unlabeled)
• Quantity: 50 μg
• Source: Chinese Hamster Ovary cell line, CHO-derived human VSIG8 protein Human VSIG8 (Val22-Gly263) (N-terminus) Accession # Q5VU13 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Biotin
• Cross Reactivity: VSIG8
• Species: Human
• Reconstitution: Reconstitute at 200 μg/mL aq. soln..
• Buffer: Lyophilized from a 0.2μm filtered solution in Sodium Acetate and Mannitol with Trehalose.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: VSIG8